Buy or sell Precision BioSciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Precision BioSciences Stock

Precision BioSciences is a biotechnology company dedicated to improving life.

Founded

2006

Headquarters

Durham NC, US

Total Funding

$175M

About Precision BioSciences Stock

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Funding History

March 2006$0
May 2015$25.6M
June 2018$110M
March 2019$39.5M

Management

Co-Founder and Chief Executive Officer

Matthew Kane

Director of Human Resources

Molly Lukes

Chief Development Officer, Executive Vice President

David Thomson

CEO, Elo

Fayaz Khazi

Co-Founder and Chief Technical Officer

Jeff Smith

Co-Founder and Chief Scientific Officer

Derek Jantz

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Precision BioSciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo